Sarah Dyball
Oxford Road
Manchester, ENG, United Kingdom
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Refining Human Phenotype Ontology (HPO) to enable better phenotype-genotype integration in systemic autoimmune rheumatic diseases.
Journal: Orphanet journal of rare diseases
Published: January 26, 2026
LupusGPT: an AI-driven information model for patients with systemic lupus erythematosus.
Journal: The Lancet. Rheumatology
Published: July 31, 2025
Experiences and unmet needs of persons living with systemic lupus erythematosus in Europe: Lupus Europe's 2024 Swiss knife survey.
Journal: Autoimmunity reviews
Published: April 09, 2025
High throughput multiplex immunoassays stratify patients according to symptom burden across the anti-Ro positive systemic autoimmune rheumatic disease spectrum.
Journal: Autoimmunity
Published: November 28, 2024
Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohort.
Journal: Seminars in arthritis and rheumatism
Published: February 07, 2024
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges.
Journal: International journal of rheumatic diseases
Published: January 03, 2024
Coalition for Health and Gender Equity (CHANGE)-a protocol for a global cross-sectional survey of health and gender equity in rheumatology.
Journal: Rheumatology advances in practice
Published: December 05, 2023
Added IMPACT: The first successful natural birth using certolizumab in obstetric APS.
Journal: Thrombosis research
Published: November 13, 2023
Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review update.
Journal: Seminars in arthritis and rheumatism
Published: August 13, 2023
An imperfect world: assessing safety of biological treatments in systemic lupus erythematosus. Comment on the article by Materne et al.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 04, 2023
Cholesteryl ester transfer protein inhibition is associated with reduced risk of Sjögren's syndrome.
Cholesteryl ester transfer protein inhibition is associated with reduced risk of Sjögren's syndrome.
Journal: Rheumatology (Oxford, England)
Published: March 01, 2023
Last Updated: 09/26/2026